New Delhi, Oct 21 (PTI) Drug firm Lupin on Monday said it has appointed Claus Jepsen as President, Global Specialty business.

Jepsen joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for rare diseases.

Also Read | What Is Digital Gold? How To Buy It Online in India? All About Investing in Digital Gold Ahead of Diwali and Dhanteras 2024.

"His experience in leading specialty strategy, commercial planning and portfolio choices across key markets will enable us to build our Specialty brand business," Lupin CEO Vinita Gupta said.

(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)